New Key Statistics Module, Z-Score and F-Score
SZSE:002826 Key Ratios
Market Cap ¥ M | 1,729.45 |
Enterprise Value ¥ M | 1,310.90 |
P/E(ttm) | 47.74 |
PE Ratio without NRI | 37.63 |
Forward PE Ratio | -- |
Price/Book | 2.31 |
Price/Sales | 2.53 |
Price/Free Cash Flow | 10.11 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.41 |
Revenue (TTM) ¥ M | 656.00 |
EPS (TTM) ¥ | 0.19 |
Beneish M-Score | -4.03 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 6.20 |
y-y EBITDA Growth Rate % | -10.90 |
EV-to-EBIT | 28.32 |
EV-to-EBITDA | 28.32 |
PEG | 6.07 |
Shares Outstanding M | 190.68 |
Net Margin (%) | 5.32 |
Operating Margin % | 8.43 |
Pre-tax Margin (%) | 6.93 |
Quick Ratio | 2.62 |
Current Ratio | 2.85 |
ROA % (ttm) | 3.57 |
ROE % (ttm) | 4.64 |
ROIC % (ttm) | 8.99 |
Dividend Yield % | 1.10 |
Altman Z-Score | 7.34 |
SZSE:002826 Number of Guru Trades
SZSE:002826 Volume of Guru Trades
Gurus Latest Trades with SZSE:002826
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:002826 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Tibet Aim Pharm Inc Insider Transactions
No Available Data